Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net sales	$ 110,248	$ 49,590
Operating expenses
Cost of goods sold	22,634	13,318
Research and development	20,966	25,160
Selling, general and administrative	137,745	125,718
Amortization of Intangible Assets	10,843	550
Total operating expenses	192,188	164,746
Loss from operations	(81,940)	(115,156)
Other income (expense)
Interest and other income	2,578	313
Interest expense	15,325	7,180
Change in fair value of warrants	1,760	(702)
Change in fair value of contingent value rights	(3,157)	0
Other income (expense)	(14,144)	(7,569)
Net loss before benefit from income taxes	(96,084)	(122,725)
Benefit from income taxes	1,424	0
Net loss	(94,660)	(122,725)
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	7	(38)
Foreign currency translation adjustments	1	1
Comprehensive loss	$ (94,652)	$ (122,762)
Net loss per common share - basic (in dollars per share)	$ (0.70)	$ (1.55)
Net loss per common share - Diluted (in dollars per share)	$ (0.70)	$ (1.55)
Weighted average common shares outstanding - basic (in shares)	135,628,721	79,027,062
Weighted average common shares outstanding - Diluted (in shares)	135,628,721	79,027,062
Product revenue, net
Net sales	$ 109,263	$ 49,280
Royalty, contract and other revenue
Net sales	$ 985	$ 310